Digital Health Coaching for Multiple Myeloma

This trial aims to determine if a digital health coaching program can assist individuals in managing life with relapsed or refractory multiple myeloma, a type of blood cancer. Participants will receive weekly phone support and educational materials and will use a Fitbit to track their activity. The study will evaluate the program's impact on quality of life, symptom management, and healthcare usage. Individuals who have begun at least a second round of treatment for multiple myeloma and have experience with certain medications may be suitable candidates. As an unphased study, this trial provides a unique opportunity to explore innovative support methods for enhancing daily life with multiple myeloma.

The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on digital health coaching rather than medication changes.

Research shows that digital health coaching is generally easy for people to use. Studies have tested its simplicity and acceptability for patients, and so far, people find it helpful and manageable.

Regarding the Fitbit, studies have found it useful for tracking physical activity in patients with myeloma. People can use it comfortably without major issues. The Fitbit helps monitor health and predict outcomes, making it a valuable part of health management.

Researchers are excited about the Digital Health Coaching program for multiple myeloma because it offers a new, tech-savvy approach to patient care. Unlike traditional treatments that focus on chemotherapy and medications, this program leverages digital health tools to enhance patients' well-being and monitor their physical activity through a Fitbit device. By providing personalized health coaching and real-time activity tracking, this method aims to empower patients with more control over their health, potentially improving outcomes in a holistic and sustainable way.

Research has shown that digital health coaching can enhance the quality of life for individuals with relapsed or refractory multiple myeloma. This trial features a single arm where all participants will engage in a 3-month digital health coaching program. Participants will also wear a Fitbit device daily to capture physical activity data. Studies have found that devices like Fitbits effectively track physical activity, which can help predict health outcomes in cancer patients. In four out of six studies, patients using these devices experienced positive effects. Combining coaching with wearable technology may simplify health management and progress tracking.¹³⁴⁶⁷